Celecoxib/Olmesartan

塞来昔布/奥美沙坦

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCelecoxib/Olmesartan
Drug Alias NameOlmesartan+Celecoxib奥美沙坦/塞来昔布Olmesartan/Celecoxib奥美沙坦+塞来昔布塞来昔布+奥美沙坦 +[7] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsCyclooxygenase-2 inhibitors
TargetsAngiotensin II Receptor Type 1Cyclooxygenase-2
Therapy Area/IndicationsInflammationHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Olmesartan MedoxomilCelecoxib
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesMarina Biotech
China Registration ClassN/A

Develop Information

Active CompaniesMarina Biotech
Inactive CompaniesN/A
Active IndicationsInflammationHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A